Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Tekmira Pharmaceuticals Corp

+ Add to Watchlist

TKMR:US

18.9700 USD 0.4300 2.22%

As of 20:10:00 ET on 04/17/2015.

Snapshot for Tekmira Pharmaceuticals Corp (TKMR)

Open: 19.2200 Day's Range: 18.8300 - 19.4000 Volume: 539,542
Previous Close: 19.4000 52wk Range: 8.8600 - 29.9300 1-Yr Rtn: +45.36%

Stock Chart for TKMR

No chart data available.
  • TKMR:US 18.9700
  • 1D
  • 1M
  • 1Y
19.4000
Interactive TKMR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TKMR

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -1.3140
Est. PEG Ratio -
Market Cap (M USD) 1,025.66
Shares Outstanding (M) 54.07
30 Day Average Volume 854,922
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TKMR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TKMR

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company. The Company is focused on advancing RNAi therapeutics and providing its lipid nanoparticle delivery technology to its pharmaceutical partners.

Mark J MurrayPresident/CEOBruce CousinsExec VP:Finance/CFO
Michael J AbramsExec VP/Chief Discovery OfficerMark KowalskiSenior VP/Chief Medical Officer
More Company Profile & Key Executives for TKMR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil